Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching

BACKGROUND: Clopidogrel and aspirin are antiplatelet agents that are recommended to reduce the risk of recurrent stroke and other cardiovascular events. Dual antiplatelet therapy with clopidogrel and aspirin has been shown to increase the risk of hemorrhage, but the effects of the drugs on laborator...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayasaka, Masatoshi, Takahashi, Yasuo, Nishida, Yayoi, Yoshida, Yoshikazu, Hidaka, Shinji, Asai, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578669/
https://www.ncbi.nlm.nih.gov/pubmed/23440682
http://dx.doi.org/10.2147/VHRM.S39351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578669/
https://www.ncbi.nlm.nih.gov/pubmed/23440682
http://dx.doi.org/10.2147/VHRM.S39351

Ejemplares similares